Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
Top News The 6 Best Nail Lamps for a Salon-Quality Manicure at HomeBy Admin0 To understand the new smart watched and other pro devices of recent focus, we should look to Silicon Valley and…
Top News IE is Dead as Microsoft Kills Off 25-Year-Old BrowserBy Admin0 To understand the new smart watched and other pro devices of recent focus, we should look to Silicon Valley and…
Top News Apple Patents a Periscopic Zoom Camera Lens for Future iPhoneBy Admin0 To understand the new smart watched and other pro devices of recent focus, we should look to Silicon Valley and…
